This inventor holds 1 USPTO granted patent. Top assignee: Pharmos Corporation. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Anat Biegnon: Innovator in Steroid Hormone Derivatives
Introduction
Anat Biegnon is a prominent inventor based in Tel Aviv, Israel. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of steroid hormone derivatives. Her innovative work has the potential to impact various therapeutic areas, including anti-inflammatory and anti-tumor treatments.
Latest Patents
Anat Biegnon holds a patent for "Permanently ionic derivatives of steroid hormones and their antagonists." This patent relates to compounds that can be utilized as anti-inflammatory and anti-tumor agents. The compounds are characterized by a general formula that includes steroid agonists or antagonists, as well as mixed agonist-antagonist and partial agonist forms. She has 1 patent to her name, showcasing her innovative contributions to the field.
Career Highlights
Anat Biegnon is associated with Pharmos Corporation, where she continues to advance her research and development efforts. Her work at the company focuses on creating novel therapeutic agents that can address significant medical needs. Her expertise in steroid hormone derivatives positions her as a key player in the pharmaceutical industry.
Collaborations
Anat collaborates with Marcus E Brewster, who is also involved in her research endeavors. Their partnership enhances the innovative potential of their projects and contributes to the advancement of their shared goals in pharmaceutical development.
Conclusion
Anat Biegnon's work in the field of steroid hormone derivatives exemplifies her commitment to innovation and therapeutic advancement. Her contributions are paving the way for new treatments that could benefit many patients in need.